Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/21/2012 | WO2012080472A1 Methods of making cell carrier |
06/21/2012 | WO2012080248A1 Method to generate dopaminergic neurons from mouse and human cells |
06/21/2012 | WO2012079679A1 Dry granulated cell culture media |
06/21/2012 | WO2012079488A1 P28gank monoclonal antibody and peptides for preparation thereof and use thereof |
06/21/2012 | WO2012079278A1 Method for preparing induced pluripotent stem cells and culture medium used for preparing induced pluripotent stem cells |
06/21/2012 | WO2012079142A1 Biopolymer composition for encapsulating cells, method for producing a biopolymer composition for encapsulating cells, method for promoting cell cytoprotection and use of a biopolymer composition for encapsulating cells |
06/21/2012 | WO2012079132A1 Arthroscopy method |
06/21/2012 | WO2012050627A3 Dopaminergic neurons derived from induced pluripotent stem cells and method of making same |
06/21/2012 | WO2012048010A3 Compositions of adult organ stem cells and uses thereof |
06/21/2012 | WO2012046065A3 Culture method for culturing pluripotent cells comprising an inhibitor of mirna- 181a* |
06/21/2012 | WO2012034101A3 Expandable cell source of neuronal stem cell populations and methods for obtaining and using them |
06/21/2012 | WO2012027376A3 Method for expansion of stem cells and the use of such cells |
06/21/2012 | WO2009125999A8 Human host cell for producing recombinant proteins with high quality and quantity |
06/21/2012 | US20120159674 Combined Use of Vip3Ab and Cry1Ab for Management of Resistant Insects |
06/21/2012 | US20120159673 Gene for increasing plant weight and method for using the same |
06/21/2012 | US20120159672 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
06/21/2012 | US20120159670 Regulatory Nucleic Acid Molecules for Enhancing Seed-Specific and/or Seed-Preferential Gene Expression in Plants |
06/21/2012 | US20120159667 Variants of nrr activate plant disease resistance |
06/21/2012 | US20120159665 Hybrid tomato ps01544291 and parent lines thereof |
06/21/2012 | US20120159664 Transgenic Plants With Enhanced Agronomic Traits |
06/21/2012 | US20120159663 Pepper hybrid ps09967922 |
06/21/2012 | US20120159662 Pepper hybrid ps09979325 |
06/21/2012 | US20120159661 T-Bet Compositions and Methods of Use Thereof |
06/21/2012 | US20120159660 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids |
06/21/2012 | US20120159657 Compositions and Methods for Inhibiting Expression of RRM2 Genes |
06/21/2012 | US20120159654 Genome editing of genes involved in adme and toxicology in animals |
06/21/2012 | US20120159653 Genomic editing of genes involved in macular degeneration |
06/21/2012 | US20120157717 Methods and compositions for producing linear alkyl benzenes |
06/21/2012 | US20120157667 Methods Of Producing Humanized Non-Human Mammals |
06/21/2012 | US20120157666 Interferon-like proteins and uses thereof |
06/21/2012 | US20120157665 Gram-positive bacteria specific binding compounds |
06/21/2012 | US20120157663 Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same |
06/21/2012 | US20120157662 Means and methods for producing high affinity antibodies |
06/21/2012 | US20120157522 B. Anthracis Prevention and Treatment: Mutant B. Anthracis Lacking Luxs Activity and Furanone Inhibition of Growth, AI-2 Quorum Sensing, and Toxin Production |
06/21/2012 | US20120157514 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
06/21/2012 | US20120157512 Preventing and Curing Beneficial Insect Diseases Via Plant Transcribed Molecules |
06/21/2012 | US20120157511 5' phosphate mimics |
06/21/2012 | US20120157510 Controlling The Potential Of Primate Neural Stem Cells By Regulating Pax6 |
06/21/2012 | US20120157507 USP47 Inhibtors and Methods to Induce Apoptosis |
06/21/2012 | US20120157481 Tricyclic pyrimidine derivatives as wnt antagonists |
06/21/2012 | US20120157474 Methods of Identifying and Using General or Alternative Splicing Inhibitors |
06/21/2012 | US20120157465 Dna methylation inhibitors |
06/21/2012 | US20120157455 Compounds And Compositions For Treating Cancer |
06/21/2012 | US20120157426 Mutant-selective egfr inhibitors and uses thereof |
06/21/2012 | US20120157398 Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity |
06/21/2012 | US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity |
06/21/2012 | US20120157381 Compositions and methods for cardiac tissue repair |
06/21/2012 | US20120157331 Methods of detecting susceptibility to leukemia/ lymphoma and induction of leukemia and lymphomas |
06/21/2012 | US20120156785 Methods and products for biasing cellular development |
06/21/2012 | US20120156784 Methods for Improving Competency of Plant Cells |
06/21/2012 | US20120156783 Automated liquid manufacturing system |
06/21/2012 | US20120156782 Cell culture medium |
06/21/2012 | US20120156781 Temperature-responsive cell culture substrate on which a straight-chain temperature-responsive polymer is immobilized, and manufacturing method therefor |
06/21/2012 | US20120156780 Polymer Substrates Having Improved Biological Response From HKDCS |
06/21/2012 | US20120156779 Method for cell expansion |
06/21/2012 | US20120156778 Method for efficient production of induced pluripotent stem cells utilizing cells derived from oral mucosa |
06/21/2012 | US20120156777 Cell carrier, associated methods for making cell carrier and culturing cells using the same |
06/21/2012 | US20120156776 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays |
06/21/2012 | US20120156775 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays |
06/21/2012 | US20120156774 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays |
06/21/2012 | US20120156773 Cell carrier, methods of making and use |
06/21/2012 | US20120156772 Cell carrier and methods of making |
06/21/2012 | US20120156771 Functional disruption of an immunoglobulin gene in an avian embryonic stem cell |
06/21/2012 | US20120156770 Human androgen receptor alternative splice variants |
06/21/2012 | US20120156769 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays |
06/21/2012 | US20120156755 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
06/21/2012 | US20120156751 Preparation and isolation of 5' capped mrna |
06/21/2012 | US20120156749 Separating material and method for collecting cell or the like using the same |
06/21/2012 | US20120156725 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors |
06/21/2012 | US20120156724 Humanized anti-cd47 antibody |
06/21/2012 | US20120156722 Tumor Suppressor Gene |
06/21/2012 | US20120156713 Method for analyzing and/or treating a fertilized egg, and corresponding system |
06/21/2012 | US20120156704 In vitro method for detecting gp91phox as a marker of oxidative stress |
06/21/2012 | US20120156696 container for forming a cell aggregate and a method for forming a cell aggregate |
06/21/2012 | US20120156695 Microorganism for expressing a human membrane protein |
06/21/2012 | US20120156672 Novel stringent selectable markers |
06/21/2012 | US20120156312 Compositions for Inhibiting Growth of Cancer Stem Cells |
06/21/2012 | US20120156305 Methods for enhancing genome stability and telomere elongation in embryonic stem cells |
06/21/2012 | US20120156254 Recombinant laminin-521 |
06/21/2012 | US20120156249 Genetically modified organism for the production of lipids |
06/21/2012 | US20120156246 Reprogramming cancer cells |
06/21/2012 | US20120156241 Rescue of influenza virus |
06/21/2012 | US20120156232 Cancer vaccines and vaccination methods |
06/21/2012 | US20120156231 Foxm1 peptides and vaccines containing the same |
06/21/2012 | US20120156223 Method for Inhibiting Scavenger Receptor-A and Increasing Immune Response to Antigens |
06/21/2012 | US20120156222 Prevention and treatment of alzheimer's disease |
06/21/2012 | US20120156217 Novel EGFR-Binding Molecules and Immunoconjugates Thereof |
06/21/2012 | US20120156210 Methods of treatment using anti-il-22ra antibodies |
06/21/2012 | US20120156207 Methods and compositions for inhibiting cd32b expressing cells |
06/21/2012 | US20120156201 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof |
06/21/2012 | US20120156198 Antibodies against IL-18R1 and uses thereof |
06/21/2012 | US20120156192 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro |
06/21/2012 | US20120156181 Therapeutic agent for liver-related diseases |
06/21/2012 | US20120156179 Method for inducing extended self-renewal of functionally differentiated somatic cells |
06/21/2012 | US20120156176 Thermoresponsive, biodegradable, elastomeric material and uses therefor |
06/21/2012 | US20120156175 Composition for inducing migration of neural stem cells containing periostin as effective ingredient |
06/21/2012 | US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming |
06/21/2012 | DE102010055287A1 Verfahren und Einrichtung zur Kultivierung und Transport aquatischer Pflanzen Method and apparatus for cultivation and transport of aquatic plants |
06/21/2012 | CA2828794A1 Cell culture medium |
06/21/2012 | CA2826252A1 Recombinant laminin-521 |